Mercier Johanna 4

4 · GILEAD SCIENCES, INC. · Filed Feb 18, 2026

AI-generated summary of this filing

Updated Feb 18, 2026

Gilead (GILD) Chief Comm Officer Johanna Mercier Exercises Options, Sells Shares

What Happened

Johanna Mercier, Gilead's Chief Communications & Corporate Affairs Officer, exercised stock options to acquire 25,000 shares at $66.64 per share (cost $1,666,000) on Feb 17, 2026. The same day she sold a total of 28,000 shares in open-market transactions (18,405 @ ~$154.18; 9,395 @ ~$154.91; 200 @ ~$155.62), generating proceeds of approximately $4,324,228. The Form 4 also reports a 25,000-share derivative disposition at $0 (see Key Details).

Key Details

Transaction date: February 17, 2026; Form 4 filed Feb 18, 2026 (timely).
Exercise: 25,000 shares acquired at $66.64 per share ($1,666,000).
Sales: 18,405 shares @ $154.18, 9,395 @ $154.91, 200 @ $155.62; total proceeds ≈ $4,324,228.
Additional derivative entry: 25,000 shares reported disposed at $0 (the filing does not specify the reason).
Sale price ranges noted in filing: roughly $153.57 to $155.62 (footnotes indicate more granular price breakdowns are available to the SEC, issuer, or shareholders).
Trades were made pursuant to a Rule 10b5-1 trading plan adopted Feb 20, 2025 (footnote).
Vesting note (footnote): related options have a four-year vesting schedule — 25% after one year, then 6.25% quarterly thereafter.
Shares owned after the transaction: not specified in this Form 4.

Context

This filing shows an option exercise coinciding with same-day open-market sales. The separate derivative disposition reported at $0 often (but not always) reflects shares withheld to cover taxes or exercise costs; the Form 4 does not state the reason here. The sales were executed under a pre-established 10b5-1 plan, which is a routine mechanism insiders use to schedule transactions.

Form 4

Period: 2026-02-17

Chief Comm & Corp Aff Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-17$66.64/sh+25,000$1,666,000→ 148,288 total
Sale
Common Stock
[F1][F2]
2026-02-17$154.18/sh−18,405$2,837,720→ 129,883 total
Sale
Common Stock
[F1][F3]
2026-02-17$154.91/sh−9,395$1,455,384→ 120,488 total
Sale
Common Stock
[F1]
2026-02-17$155.62/sh−200$31,124→ 120,288 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
[F1][F4]
2026-02-17−25,000→ 48,110 total
Exercise: $66.64Exp: 2029-07-24→ Common Stock (25,000 underlying)

Footnotes (4)

[F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F2]Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
[F3]Sale prices for the transactions reported range from $154.57 to $155.27 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
[F4]The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Signature

/s/ Edward S. Son by Power of Attorney for Johanna Mercier|2026-02-18

1 file